Halloran Consulting and Metrics Champion Consortium team up for education on clinical trial metrics
A Community of Practice (CoP) for small- to medium-sized trial sponsors is in the offing
Halloran Consulting Group (Boston), a fast-growing advisory firm on managing clinical trials, has joined the Metrics Champion Consortium (MCC; Boston) to help building up the Small/Midsize Sponsor CoP, said to be the first such effort for the life sciences community. Laurie Halloran, CEO, says that her company’s partnership is a “natural fit” in that more than half of the company’s clients are in that size range. The company has been providing administrative and advisory support to help clients manage trails and meet FDA review and approval requirements; it specializes in, among other things, properly managing the financials of clinical trials.
MCC is a nearly decade-old nonprofit that provides training, benchmarking and advice on improving clinical trial operations. It has over 80 members among drug companies, contract research organizations and service providers to the clinical trials business. Over the past year, it has been establishing workgroup for small- to mid-size firms; in the recent past, it has published surveys and guidance documents for trial master files, key performance indicators, risk-based monitoring of trials and related topics.
Together, the two are sponsoring a complimentary webinar, “How can Small Companies Benefit from Efforts to Standardize,” on Dec. 1. More information is available here.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
